Wilms tumor

References

Key articles

D'Angio GJ. The National Wilms Tumor Study: a 40 year perspective. Lifetime Data Anal. 2007 Dec;13(4):463-70. Abstract

van den Heuvel-Eibrink MM, Grundy P, Graf N, et al. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: a collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatr Blood Cancer. 2008 Jun;50(6):1130-4. Abstract

Park S, Bernard A, Bove KE, et al. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nat Genet. 1993 Dec;5(4):363-7. Abstract

Koufos A, Hansen MF, Copeland NG, et al. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature. 1985 Jul 25-31;316(6026):330-4. Abstract

Malogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008 Feb;50(2):236-41. Abstract

Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006 May 20;24(15):2352-8. Abstract

Reinhard H, Semler O, Burger D, et al. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Klin Padiatr. 2004 May-Jun;216(3):132-40. Abstract

Graf N, Tournade MF, de Kraker J. The role of preoperative chemotherapy in the management of Wilms tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am. 2000 Aug;27(3):443-54. Abstract

Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005 Oct 10;23(29):7312-21. Abstract

Presson A, Moore TB, Kempert P, et al. Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms' tumor: a meta-analysis. J Pediatr Hematol Oncol. 2010 Aug;32(6):454-61. Abstract

Reference articles

1. D'Angio GJ. The National Wilms Tumor Study: a 40 year perspective. Lifetime Data Anal. 2007 Dec;13(4):463-70. Abstract

2. Kaste SC, Dome JS, Babyn PS, et al. Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatr Radiol. 2008 Jan;38(1):2-17. Abstract

3. Breslow N, Olshan A, Beckwith JB, et al. Epidemiology of Wilms tumor. Med Pediatr Oncol. 1993;21(3):172-81. Abstract

4. Bunin GR, Meadows AT. Epidemiology and Wilms tumor: approaches and methods. Med Pediatr Oncol. 1993;21(3):169-71. Abstract

5. Green DM, Breslow NE, Beckwith JB, et al. Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study. Med Pediatr Oncol. 1993;21(3):188-92. Abstract

6. Heppe RK, Koyle MA, Beckwith JB. Nephrogenic rests in Wilms tumor patients with the Drash syndrome. J Urol. 1991 Jun;145(6):1225-8. Abstract

7. Breslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2003 Dec 15;21(24):4579-85. Abstract

8. Mahmood A, Ghafoor T, Badsha S. Wilms' tumour: presentation and treatment. J Coll Physicians Surg Pak. 2004 Mar;14(3):142-5. Abstract

9. Breslow NE, Olson J, Moksness J, et al. Familial Wilms' tumor: a descriptive study. Med Pediatr Oncol. 1996 Nov;27(5):398-403. Abstract

10. van den Heuvel-Eibrink MM, Grundy P, Graf N, et al. Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: a collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groups. Pediatr Blood Cancer. 2008 Jun;50(6):1130-4. Abstract

11. Coppes MJ, de Kraker J, van Dijken PJ, et al. Bilateral Wilms tumor: long-term survival and some epidemiological features. J Clin Oncol. 1989 Mar;7(3):310-15. Abstract

12. Montgomery BT, Kelalis PP, Blute ML, et al. Extended followup of bilateral Wilms tumor: results of the National Wilms Tumor Study. J Urol. 1991 Aug;146(2 Pt 2):514-8. Abstract

13. Ritchey ML, Shamberger RC, Hamilton T, et al. Fate of bilateral renal lesions missed on preoperative imaging: a report from the National Wilms Tumor Study Group. J Urol. 2005 Oct;174(4 Pt 2):1519-21. Abstract

14. Horwitz JR, Ritchey ML, Moksness J, et al. Renal salvage procedures in patients with synchronous bilateral Wilms tumors: a report from the National Wilms Tumor Study Group. J Pediatr Surg. 1996 Aug;31(8):1020-5. Abstract

15. Rasheed K, O'Meara A, Kelleher J, et al. Extrarenal Wilms' tumor. Eur J Pediatr Surg. 1993 Apr;3(2):121-3. Abstract

16. Coppes MJ, Wilson PC, Weitzman S. Extrarenal Wilms' tumor: staging, treatment, and prognosis. J Clin Oncol. 1991 Jan;9(1):167-74. Abstract

17. Grundy P, Breslow N, Green DM, et al. Prognostic factors for children with recurrent Wilms' tumor: results from the Second and Third National Wilms' Tumor Study. J Clin Oncol. 1989 May;7(5):638-47. Abstract

18. Perlman EJ. Pediatric renal tumors: practical updates for the pathologist. Pediatr Dev Pathol. 2005 May-Jun;8(3):320-38. Abstract

19. Petersen CL, Hemker BG, Jacobson RD, et al. Wilms tumor presenting with lambert-eaton myasthenic syndrome. J Pediatr Hematol Oncol. 2013 May;35(4):267-70. Abstract

20. Abdullah Y, Karpelowsky J, Davidson A, et al. Management of nine cases of Wilms' tumour with intracardiac extension - a single centre experience. J Pediatr Surg. 2013 Feb;48(2):394-9. Abstract

21. Ward EM, Thun MJ, Hannan LM, et al. Interpreting cancer trends. Ann N Y Acad Sci. 2006 Sep;1076(1):29-53. Abstract

22. Pastore G, Carli M, Lemerle J, et al. Epidemiological features of Wilms tumor: results of studies by the International Society of Paediatric Oncology (SIOP). Med Pediatr Oncol. 1988;16(1):7-11. Abstract

23. Breslow N, Olshan A, Beckwith JB, et al. Ethnic variation in the incidence, diagnosis, prognosis, and follow-up of children with Wilms' tumor. J Natl Cancer Inst. 1994 Jan 5;86(1):49-51. Abstract

24. Fukuzawa R, Breslow NE, Morison IM, et al. Epigenetic differences between Wilms tumours in white and east-Asian children. Lancet. 2004 Feb 7;363(9407):446-51. Abstract

25. Seyed-Ahadi MM, Khaleghnejad-Tabari A, Mirshemirani A, et al. Wilms tumor: a 10 year retrospective study. Arch Iran Med. 2007 Jan;10(1):65-9.Full text  Abstract

26. Gatta G, Capocaccia R, Stiller C, et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol. 2005 Jun 1;23(16):3742-51. Abstract

27. Chaudhuri K, Sinha A, Hati GC, et al. Childhood malignancies at BS Medical College: a ten year study. Indian J Pathol Microbiol. 2003 Apr;46(2):194-6. Abstract

28. Ben Arush MW, Nahum MP, Maor JA, et al. Wilms tumor: the Northern Israel Oncology Institute experience. J Surg Oncol. 1995 May;59(1):10-3. Abstract

29. Olisa EG, Chandra R, Jackson MA, et al. Malignant tumors in American black and Nigerian children: a comparative study. J Natl Cancer Inst. 1975 Aug;55(2):281-4. Abstract

30. Sen S, Kadamba P, Al-AbdulAaly M, et al. Results of Wilms tumour management in two tertiary-care hospitals in Asia. Pediatr Surg Int. 1998 Jan;13(1):42-4. Abstract

31. Breslow NE, Beckwith JB, Perlman EJ, et al. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer. 2006 Sep;47(3):260-7.Full text  Abstract

32. Bjornsson HT, Brown LJ, Fallin MD, et al. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst. 2007 Aug 15;99(16):1270-3.Full text  Abstract

33. Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer. 2008 Jun;47(6):461-70. Abstract

34. Breslow NE, Beckwith JB. Epidemiological features of Wilms' tumor: results of the National Wilms' Tumor Study. J Natl Cancer Inst. 1982 Mar;68(3):429-36. Abstract

35. Kaste SC, McCarville MB. Imaging pediatric abdominal tumors. Semin Roentgenol. 2008 Jan;43(1):50-9. Abstract

36. Brisse HJ, Smets AM, Kaste SC, et al. Imaging in unilateral Wilms tumour. Pediatr Radiol. 2008 Jan;38(1):18-29. Abstract

37. Ritchey ML, Green DM, Breslow NB, et al. Accuracy of current imaging modalities in the diagnosis of synchronous bilateral Wilms' tumor. A report from the National Wilms Tumor Study Group. Cancer. 1995 Jan 15;75(2):600-4. Abstract

38. Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet. 1998 Oct 2;79(4):268-73. Abstract

39. Wittmann S, Zirn B, Alkassar M, et al. Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis. Genes Chromosomes Cancer. 2007 Feb;46(2):163-70. Abstract

40. Zirn B, Samans B, Wittmann S, et al. Target genes of the WNT/beta-catenin pathway in Wilms tumors. Genes Chromosomes Cancer. 2006 Jun;45(6):565-74. Abstract

41. Zirn B, Hartmann O, Samans B, et al. Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters. Int J Cancer. 2006 Apr 15;118(4):1954-62. Abstract

42. Dome JS, Bockhold CA, Li SM, et al. High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor. J Clin Oncol. 2005 Dec 20;23(36):9138-45. Abstract

43. Nishi M, Miyake H, Takeda T, et al. Congenital malformations and childhood cancer. Med Pediatr Oncol. 2000 Apr;34(4):250-4. Abstract

44. Cooney MA, Daniels JL, Ross JA, et al. Household pesticides and the risk of Wilms tumor. Environ Health Perspect. 2007 Jan;115(1):134-7.Full text  Abstract

45. Saddlemire S, Olshan AF, Daniels JL, et al. Breast-feeding and Wilms tumor: a report from the Children's Oncology Group. Cancer Causes Control. 2006 Jun;17(5):687-93. Abstract

46. Neville H, Ritchey ML, Shamberger RC, et al. The occurrence of Wilms tumor in horseshoe kidneys: a report from the National Wilms Tumor Study Group (NWTSG). J Pediatr Surg. 2002 Aug;37(8):1134-7. Abstract

47. Green DM, Cotton CA, Malogolowkin M, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2007 May;48(5):493-9. Abstract

48. Campbell AD, Cohn SL, Reynolds M, et al. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital. J Clin Oncol. 2004 Jun 15;22(14):2885-90. Abstract

49. Kim TH, Zaatari GS, Baum ES, et al. Recurrence of Wilms tumor after apparent cure. J Pediatr. 1985 Jul;107(1):44-9. Abstract

50. Crump C, Sundquist J, Sieh W, et al. Perinatal risk factors for Wilms tumor in a Swedish national cohort. Eur J Epidemiol. 2014 Mar;29(3):191-7. Abstract

51. Coppes MJ, Beckwith JB. Clinical approach to renal lesions in children with multiple nephrogenic rests. Med Pediatr Oncol. 2000 Jul;35(1):73-4. Abstract

52. Park S, Bernard A, Bove KE, et al. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Nat Genet. 1993 Dec;5(4):363-7. Abstract

53. Beckwith JB. Management of incidentally encountered nephrogenic rests. J Pediatr Hematol Oncol. 2007 Jun;29(6):353-4. Abstract

54. Perlman E, Dijoud F, Boccon-Gibod L. Nephrogenic rests and nephroblastomatosis (in French). Ann Pathol. 2004 Dec;24(6):510-5. Abstract

55. Knudson AG Jr, Strong LC. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst. 1972 Feb;48(2):313-24. Abstract

56. Knudson AG Jr. The genetic predisposition to cancer. Birth Defects Orig Artic Ser. 1989;25(2):15-27. Abstract

57. Knudson AG Jr, Strong LC. Letter: familial Wilm's tumor. Am J Hum Genet. 1975 Nov;27(6):809-10.Full text  Abstract

58. Osterheld MC, Caron L, Meagher-Villemure K. Role of DNA content analysis and immunohistochemistry in the evaluation of the risk of unfavourable outcome in Wilms' tumours. Anticancer Res. 2008 Apr;28(2A):751-6. Abstract

59. Ogawa O, Eccles MR, Szeto J, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 1993 Apr 22;362(6422):749-51. Abstract

60. Reeve AE, Eccles MR, Wilkins RJ, et al. Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature. 1985 Sep 19-25;317(6034):258-60. Abstract

61. Koufos A, Hansen MF, Copeland NG, et al. Loss of heterozygosity in three embryonal tumours suggests a common pathogenetic mechanism. Nature. 1985 Jul 25-31;316(6026):330-4. Abstract

62. Grundy P, Koufos A, Morgan K, et al. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature. 1988 Nov 24;336(6197):374-6. Abstract

63. Francke U. Molecular genetics. A gene for Wilms tumour? Nature. 1990 Feb 22;343(6260):692-4. Abstract

64. Turnbull C, Perdeaux ER, Pernet D, et al. A genome-wide association study identifies susceptibility loci for Wilms tumor. Nat Genet. 2012 Apr 29;44(6):681-4. Abstract

65. Malogolowkin M, Cotton CA, Green DM, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008 Feb;50(2):236-41. Abstract

66. Feusner JH, Ritchey ML, Norkool PA, et al. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2008 Feb;50(2):242-5. Abstract

67. Felgenhauer JL, Barce JM, Benson RL, et al. No excess of early onset cancer in family members of Wilms tumor patients. Cancer. 2001 Sep 15;92(6):1606-12. Abstract

68. Shamberger RC, Guthrie KA, Ritchey ML, et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Ann Surg. 1999 Feb;229(2):292-7.Full text  Abstract

69. Hennigar RA, O'Shea PA, Grattan-Smith JD. Clinicopathologic features of nephrogenic rests and nephroblastomatosis. Adv Anat Pathol. 2001 Sep;8(5):276-89. Abstract

70. Perotti D, Spreafico F, Torri F, et al. Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse. Genes Chromosomes Cancer. 2012 Jul;51(7):644-53. Abstract

71. Gratias EJ, Jennings LJ, Anderson JR, et al. Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group. Cancer. 2013 Nov 1;119(21):3887-94. Abstract

72. McNeil DE, Brown M, Ching A, et al. Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model. Med Pediatr Oncol. 2001 Oct;37(4):349-56. Abstract

73. Grundy R, Pritchard J. Ascertainment of the incidence of Beckwith-Wiedemann syndrome in the National Wilms Tumor Study Group. J Clin Oncol. 2001 Jan 15;19(2):593-4.Full text  Abstract

74. Perlman EJ, Faria P, Soares A, et al. Hyperplastic perilobar nephroblastomatosis: long-term survival of 52 patients. Pediatr Blood Cancer. 2006 Feb;46(2):203-21. Abstract

75. Thomas PR, Tefft M, Farewell VT, et al. Abdominal relapses in irradiated second National Wilms Tumor Study patients. J Clin Oncol. 1984 Oct;2(10):1098-1101. Abstract

76. Coppes MJ, Arnold M, Beckwith JB, et al. Factors affecting the risk of contralateral Wilms tumor development: a report from the National Wilms Tumor Study Group. Cancer. 1999 Apr 1;85(7):1616-25. Abstract

77. Park ES, Kang HJ, Shin HY, et al. Improved survival in patients with recurrent Wilms tumor: the experience of the Seoul National University Children's Hospital. J Korean Med Sci. 2006 Jun;21(3):436-40.Full text  Abstract

78. Wilkins JR III, Sinks TH Jr. Paternal occupation and Wilms tumour in offspring. J Epidemiol Community Health. 1984 Mar;38(1):7-11.Full text  Abstract

79. Olshan AF, Breslow NE, Daling JR, et al. Wilms tumor and paternal occupation. Cancer Res. 1990 Jun 1;50(11):3212-7. Abstract

80. Yoshimoto Y, Neel JV, Schull WJ, et al. Malignant tumors during the first 2 decades of life in the offspring of atomic bomb survivors. Am J Hum Genet. 1990 Jun;46(6):1041-52.Full text  Abstract

81. Pakakasama S, Tomlinson GE. Genetic predisposition and screening in pediatric cancer. Pediatr Clin North Am. 2002 Dec;49(6):1393-413. Abstract

82. Breslow NE, Collins AJ, Ritchey ML, et al. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol. 2005 Nov;174(5):1972-5.Full text  Abstract

83. Breslow NE, Takashima JR, Ritchey ML, et al. Renal failure in the Denys-Drash and Wilms tumor-aniridia syndromes. Cancer Res. 2000 Aug 1;60(15):4030-2.Full text  Abstract

84. Pritchard J, Imeson J, Barnes J, et al. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. J Clin Oncol. 1995 Jan;13(1):124-33. Abstract

85. Shamberger RC, Haase GM, Argani P, et al. Bilateral Wilms' tumors with progressive or nonresponsive disease. J Pediatr Surg. 2006 Apr;41(4):652-7. Abstract

86. Exelby PR. Wilms' tumor 1991. Clinical evaluation and treatment. Urol Clin North Am. 1991 Aug;18(3):589-97. Abstract

87. Ehrlich RM, Bloomberg SD, Gyepes MT, et al. Wilms tumor, misdiagnosed preoperatively: a review of 19 National Wilms Tumor Study I cases. J Urol. 1979 Dec;122(6):790-2. Abstract

88. Navoy JF, Royal SA, Vaid YN, et al. Wilms tumor: unusual manifestations. Pediatr Radiol. 1995 Nov;25(suppl 1):S76-86. Abstract

89. Green DM. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol. 2004 Apr 15;22(8):1366-72. Abstract

90. McAlpine J, Azodi M, O'Malley D, et al. Extrarenal Wilms' tumor of the uterine corpus. Gynecol Oncol. 2005 Mar;96(3):892-6. Abstract

91. Graf N. Wilms tumor (in German). Praxis (Bern 1994). 1996;85:753-61. Abstract

92. Auldist AW. Wilms' tumor presenting as a varicocele. J Pediatr Surg. 1976 Jun;11(3):471-2. Abstract

93. Maas MH, Cransberg K, van Grotel M, et al. Renin-induced hypertension in Wilms tumor patients. Pediatr Blood Cancer. 2007 May;48(5):500-3. Abstract

94. Szavay P, Luithle T, Semler O, et al. Surgery of cavoatrial tumor thrombus in nephroblastoma: a report of the SIOP/GPOH study. Pediatr Blood Cancer. 2004 Jul;43(1):40-5. Abstract

95. Provenzi M, Saettini F, Conter V, et al. Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review. Pediatr Hematol Oncol. 2013 Oct;30(7):633-9. Abstract

96. Arul GS, Gornall P. Is partial nephrectomy feasible in unilateral Wilms tumour? Results from the UKCCSG study (UKW-3). Pediatr Blood Cancer. 2004 Dec;43(7):792. Abstract

97. Grundy RG, Hutton C, Middleton H, et al. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study. Pediatr Blood Cancer. 2004 Apr;42(4):311-9. Abstract

98. Vujanic GM, Kelsey A, Mitchell C, et al. The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms tumor study 3. Med Pediatr Oncol. 2003 Jan;40(1):18-22. Abstract

99. Mitchell C, Pritchard-Jones K, Shannon R, et al. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. Eur J Cancer. 2006 Oct;42(15):2554-62. Abstract

100. Diller L, Ghahremani M, Morgan J, et al. Constitutional WT1 mutations in Wilms tumor patients. J Clin Oncol. 1998 Nov;16(11):3634-40. Abstract

101. Davidoff AM, Soutter AD, Shochat SJ. Wilms tumor presenting with abdominal pain: a special subgroup of patients. Ann Surg Oncol. 1998 Apr-May;5(3):213-5. Abstract

102. Rosenfeld M, Rodgers BM, Talbert JL. Wilms' tumor with acute abdominal pain. Arch Surg. 1977 Sep;112(3):1080-2. Abstract

103. Green DM. Diagnosis and management of malignant solid tumors in infants and children. Boston, Martinus: Nijhoff Publishing; 1985.

104. Davidson A, Hartley PS, Shuttleworth MH. Erythrocytosis and iron deficiency anemia in Wilms tumor. J Pediatr Hematol Oncol. 2005 Sep;27(9):502. Abstract

105. Czauderna P, Katski K, Kowalczyk J, et al. Venoocclusive liver disease (VOD) as a complication of Wilms' tumour management in the series of consecutive 206 patients. Eur J Pediatr Surg. 2000 Oct;10(5):300-3. Abstract

106. Batra S, Perelman N, Luck LR, et al. Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest. 2003 Oct;83(10):1477-87. Abstract

107. Ritchey ML, Green DM, Thomas PR, et al. Renal failure in Wilms' tumor patients: A report from the National Wilms' Tumor Study Group. Med Pediatr Oncol. 1996 Feb;26(2):75-80. Abstract

108. Coppes MJ, Zandvoort SW, Sparling CR, et al. Acquired von Willebrand disease in Wilms' tumor patients. J Clin Oncol. 1992 Mar;10(3):422-7. Abstract

109. Amar AM, Tomlinson G, Green DM, et al. Clinical presentation of rhabdoid tumors of the kidney. J Pediatr Hematol Oncol. 2001 Feb;23(2):105-8. Abstract

110. Ritchey ML, Kelalis PP, Breslow N, et al. Intracaval and atrial involvement with nephroblastoma: review of National Wilms Tumor Study-3. J Urol. 1988 Nov;140(5 Pt 2):1113-8. Abstract

111. Caiulo VA, Latini G, Cataldi L, et al. Nephrogenic rests: their frequency and their fate. J Pediatr Hematol Oncol. 2007 Jun;29(6):361-3. Abstract

112. de Kraker J, Lemerle J, Voute PA, et al. Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. J Clin Oncol. 1990 Jul;8(7):1187-90. Abstract

113. Wilimas JA, Douglass EC, Magill HL, et al. Significance of pulmonary computed tomography at diagnosis in Wilms' tumor. J Clin Oncol. 1988 Jul;6(7):1144-6. Abstract

114. Khanna G, Rosen N, Anderson JR, et al. Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012 Apr;58(4):551-5. Abstract

115. Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006 May 20;24(15):2352-8. Abstract

116. Beckwith JB. National Wilms Tumor Study: an update for pathologists. Pediatr Dev Pathol. 1998 Jan-Feb;1(1):79-84. Abstract

117. Green DM, Breslow NE, Evans I, et al. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. Med Pediatr Oncol. 1996 Mar;26(3):147-52. Abstract

118. Gratias EJ, Dome JS. Current and emerging chemotherapy treatment strategies for Wilms tumor in North America. Paediatr Drugs. 2008 Aug;10(2):115-24. Abstract

119. Spreafico F, Terenziani M, Fossati-Bellani F, et al. Revised SIOP working classification of renal tumors of childhood. Med Pediatr Oncol. 2003 Jul;41(1):102. Abstract

120. Reinhard H, Semler O, Burger D, et al. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor. Klin Padiatr. 2004 May-Jun;216(3):132-40. Abstract

121. de Kraker J, Graf N, van Tinteren H, et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet. 2004 Oct 2-8;364(9441):1229-35. Abstract

122. Dickson PV, Sims TL, Streck CJ, et al. Avoiding misdiagnosing neuroblastoma as Wilms tumor. J Pediatr Surg. 2008 Jun;43(6):1159-63. Abstract

123. Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am. 2008 Feb;55(1):97-120. Abstract

124. Kohler JA, Ellershaw C, Machin D. Response to N7 induction chemotherapy in children more than one year of age diagnosed with metastatic neuroblastoma treated in UKCCSG centers. Pediatr Blood Cancer. 2007 Sep;49(3):234-9. Abstract

125. George RE, London WB, Cohn SL, et al. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 2005 Sep 20;23(27):6466-73. Abstract

126. Skotnicka-Klonowicz G, Rieske P, Bartkowiak J, et al. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance. Eur J Surg Oncol. 2000 Feb;26(1):61-6. Abstract

127. Ng A, Jenkinson H, Morland B, et al. Clear cell sarcoma: a dilemma on pathological staging and clinical management. Pediatr Hematol Oncol. 2005 Apr-May;22(3):257-61. Abstract

128. Green DM, Grigoriev YA, Nan B, et al. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. J Clin Oncol. 2001 Apr 1;19(7):1926-34. Abstract

129. Zisman A, Pantuck AJ, Wieder J, et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol. 2002 Dec 1;20(23):4559-66. Abstract

130. Gold PJ, Fefer A, Thompson JA. Paraneoplastic manifestations of renal cell carcinoma. Semin Urol Oncol. 1996 Nov;14(4):216-22. Abstract

131. Tomlinson GE, Breslow NE, Dome J, et al. Rhabdoid tumor of the kidney in the National Wilms Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol. 2005 Oct 20;23(30):7641-5. Abstract

132. Bourdeaut F, Freneaux P, Thuille B, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol. 2007 Feb;211(3):323-30. Abstract

133. Avner ED, Sweeney WE Jr. Renal cystic disease: new insights for the clinician. Pediatr Clin North Am. 2006 Oct;53(5):889-909. Abstract

134. Armstrong R, Sridhar M, Greenhalgh KL, et al. Phaeochromocytoma in childhood. Arch Dis Child. 2008 Oct;93(10):627.

135. Reiter A, Klapper W. Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. Br J Haematol. 2008 Jul;142(3):329-47. Abstract

136. Green DM, Breslow NE, Beckwith JB, et al. Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 2001;19:3719-3724. Abstract

137. Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse anaplasia in Wilms tumor - new definitions with prognostic significance: a report from the National Wilms Tumor Study Group. Am J Surg Pathol. 1996 Aug;20(8):909-20. Abstract

138. Ritchey ML, Pringle KC, Breslow NE, et al. Management and outcome of inoperable Wilms tumor. A report of National Wilms Tumor Study-3. Ann Surg. 1994 Nov;220(5):683-90.Full text  Abstract

139. Green DM, Beckwith JB, Breslow NE, et al. Treatment of children with stages II to IV anaplastic Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 1994 Oct;12(10):2126-31. Abstract

140. Graf N, Tournade MF, de Kraker J. The role of preoperative chemotherapy in the management of Wilms tumor. The SIOP studies. International Society of Pediatric Oncology. Urol Clin North Am. 2000 Aug;27(3):443-54. Abstract

141. Vujanic GM, Sandstedt B. The pathology of Wilms' tumour (nephroblastoma): the International Society of Paediatric Oncology approach. J Clin Pathol. 2010 Feb;63(2):102-9. Abstract

142. Greene AK, Kieran M, Burrows PE, et al. Wilms tumor screening is unnecessary in Klippel-Trenaunay syndrome. Pediatrics. 2004 Apr;113(4):326-9.Full text  Abstract

143. Israels T, Moreira C, Scanlan T, et al. SIOP PODC: clinical guidelines for the management of children with Wilms tumour in a low income setting. Pediatr Blood Cancer. 2013 Jan;60(1):5-11.Full text  Abstract

144. Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005 Oct 10;23(29):7312-21. Abstract

145. de Kraker J, Jones KP. Treatment of Wilms tumor: an international perspective. J Clin Oncol. 2005 May 1;23(13):3156-7. Abstract

146. Weirich A, Ludwig R, Graf N, et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol. 2004 May;15(5):808-20.Full text  Abstract

147. Porteus MH, Narkool P, Neuberg D, et al. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2000 May;18(10):2026-31. Abstract

148. Aspiazu D, Fernandez-Pineda I, Cabello R, et al. Surgical management of Wilms tumor with intravascular extension: a single-institution experience. Pediatr Hematol Oncol. 2012 Feb;29(1):50-4. Abstract

149. Duarte RJ, Cristofani LM, Dénes FT, et al. Wilms tumor: a retrospective study of 32 patients using videolaparoscopic and open approaches. Urology. 2014 Jul;84(1):191-5. Abstract

150. Brisse HJ, Schleiermacher G, Sarnacki S, et al. Preoperative Wilms tumor rupture: a retrospective study of 57 patients. Cancer. 2008 Jul 1;113(1):202-13. Abstract

151. Rutigliano DN, Kayton ML, Steinherz P, et al. The use of preoperative chemotherapy in Wilms tumor with contained retroperitoneal rupture. J Pediatr Surg. 2007 Sep;42(9):1595-9. Abstract

152. Seseke F, Rebmann S, Zoller G, et al. Risk factors for perioperative complications in renal surgery for Wilms tumor (in German). Aktuelle Urol. 2007 Jan;38(1):46-51. Abstract

153. Safdar CA, Aslam M, Awan SH, et al. Wilms' tumour: a comparison of surgical aspects in patients with or without pre-operative chemotherapy. J Coll Physicians Surg Pak. 2006 Aug;16(8):521-4. Abstract

154. Paya K, Horcher E, Lawrenz K, et al. Bilateral Wilms tumor - surgical aspects. Eur J Pediatr Surg. 2001 Apr;11(2):99-104. Abstract

155. Breslow N, Sharples K, Beckwith JB, et al. Prognostic factors in nonmetastatic, favorable histology Wilms tumor: results of the Third National Wilms Tumor Study. Cancer. 1991 Dec 1;68(11):2345-53. Abstract

156. Breslow N, Churchill G, Beckwith JB, et al. Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis: results of the second National Wilms Tumor Study. J Clin Oncol. 1985 Apr;3(4):521-31. Abstract

157. Goodwin WE. The national Wilms tumor study: a progress report. J Urol. 1974 Oct;112(4):413. Abstract

158. Reinhard H, Aliani S, Ruebe C, et al. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. J Clin Oncol. 2004 Nov 15;22(22):4500-6. Abstract

159. Graf N, Semler O, Reinhard H. Prognosis of Wilm's tumor in the course of the SIOP trials and studies (in German). Urologe A. 2004 Apr;43(4):421-8. Abstract

160. Burger D, Moorman-Voestermans CG, Mildenberger H, et al. The advantages of preoperative therapy in Wilms tumour: a summarised report on clinical trials conducted by the International Society of Paediatric Oncology (SIOP). Z Kinderchir. 1985 Jun;40(3):170-5. Abstract

161. D'Angio GJ. SIOP (International Society of Paediatric Oncology) and the management of Wilms' tumor. J Clin Oncol. 1983 Oct;1(10):595-6. Abstract

162. Ablett S, Pinkerton CR. Recruiting children into cancer trials - role of the United Kingdom Children's Cancer Study Group (UKCCSG). Br J Cancer. 2003 Jun 2;88(11):1661-5.Full text  Abstract

163. Mitchell C, Jones PM, Kelsey A, et al. The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour study. Br J Cancer. 2000 Sep;83(5):602-8.Full text  Abstract

164. Godzinski J, Tournade MF, de Kraker J, et al. The role of preoperative chemotherapy in the treatment of nephroblastoma: the SIOP experience. Societe Internationale d'Oncologie Pediatrique. Semin Urol Oncol. 1999 Feb;17(1):28-32. Abstract

165. Lemerle J, Voute PA, Tournade MF, et al. Effectiveness of preoperative chemotherapy in Wilms tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol. 1983 Oct;1(10):604-9. Abstract

166. de Kraker J, Voute PA, Lemerle J, et al. Preoperative chemotherapy in Wilms tumour. Results of clinical trials and studies on nephroblastomas conducted by the International Society of Paediatric Oncology (SIOP). Prog Clin Biol Res. 1982;100:131-44. Abstract

167. Levie NS, de Kraker J, Bokkerink JP, et al. SIOP treatment guidelines for renal tumours in small infants: fact or fantasy? Eur J Surg Oncol. 2000 Sep;26(6):567-70. Abstract

168. Hempel L, Kremens B, Weirich A, et al. High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study. Klin Padiatr. 1996 Jul-Aug;208(4):186-9. Abstract

169. Greenberg M, Burnweit C, Filler R, et al. Preoperative chemotherapy for children with Wilms' tumor. J Pediatr Surg. 1991 Aug;26(8):949-53. Abstract

170. Bogaert GA, Heremans B, Renard M, et al. Does preoperative chemotherapy ease the surgical procedure for Wilms tumor? J Urol. 2009 Oct;182(4 suppl):1869-1874. Abstract

171. Zoeller G, Pekrun A, Lakomek M, et al. Staging problems in the pre-operative chemotherapy of Wilms' tumour. Br J Urol. 1995 Oct;76(4):501-3. Abstract

172. D'Angio GJ. Successful symbiosis: Norman E. Breslow, Ph.D. and the National Wilms Tumor Study. Lifetime Data Anal. 2007 Dec;13(4):443-4. Abstract

173. Breslow NE, Beckwith JB, Haase GM, et al. Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):203-9.Full text  Abstract

174. Canning DA. Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study. J Urol. 2005 Aug;174(2):719-20. Abstract

175. Kalapurakal JA, Peterson S, Peabody EM, et al. Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1364-8. Abstract

176. Flentje M, Weirich A, Graf N, et al. Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival. Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):163-9. Abstract

177. Taylor RE. Morbidity from abdominal radiotherapy in the First United Kingdom Children's Cancer Study Group Wilms Tumour Study. United Kingdom Children's Cancer Study Group. Clin Oncol (R Coll Radiol). 1997;9(6):381-4. Abstract

178. Green DM, Breslow NE, Beckwith JB, et al. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms tumors: a report from the National Wilms Tumor Study. J Clin Oncol. 1993 Jan;11(1):91-5. Abstract

179. Kalapurakal JA, Nan B, Norkool P, et al. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1379-84. Abstract

180. Green DM. The evolution of treatment for Wilms tumor. J Pediatr Surg. 2013 Jan;48(1):14-19. Abstract

181. Grundy PE, Green DM, Dirks AC, et al. Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2012 Oct;59(4):631-5. Abstract

182. Oesterling JE, Jeffs RD. Metachronous bilateral Wilms tumor. Report of longest-known survivor and guidelines for conservative management. Urology. 1987 Oct;30(4):341-6. Abstract

183. Ehrlich RM, Shanberg AM, Asch MJ, et al. Bilateral nephrectomy for Wilms tumor. J Urol. 1986 Jul;136(1 Pt 2):308-11. Abstract

184. Regalado JJ, Rodriguez MM, Toledano S. Bilaterally multicentric synchronous Wilms' tumor: successful conservative treatment despite persistence of nephrogenic rests. Med Pediatr Oncol. 1997 Jun;28(6):420-3. Abstract

185. Aronson DC, Slaar A, Heinen RC, et al. Long-term outcome of bilateral Wilms tumors (BWT). Pediatr Blood Cancer. 2011 Jul 1;56(7):1110-3. Abstract

186. Pritchard-Jones K, Moroz V, Vujanic G, et al. Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial. Ann Oncol. 2012 Sep;23(9):2457-63. Abstract

187. Berger M, Fernandez-Pineda I, Cabello R, et al. The relationship between the site of metastases and outcome in children with stage IV Wilms tumor: data from 3 European pediatric cancer institutions. J Pediatr Hematol Oncol. 2013 Oct;35(7):518-24. Abstract

188. Boglino C, Inserra A, Madafferi S. A single-institution Wilms' tumor and localized neuroblastoma series. Acta Paediatr Suppl. 2004 May;93(445):74-7. Abstract

189. Cozzi F, Schiavetti A, Morini F, et al. Re: partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93-01/GPOH. J Urol. 2004 Jun;171(6 Pt 1):2383. Abstract

190. Acosta D, Martinez-Ibanez V, Lloret J, et al. Partial nephrectomy in unilateral Wilms tumor. New draft for a protocol of the SIOP (in Spanish). Cir Pediatr. 2001 Oct;14(4):139-40. Abstract

191. Hamilton TE, Ritchey ML, Haase GM, et al. The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group. Ann Surg. 2011 May;253(5):1004-10. Abstract

192. Kieran K, Davidoff AM. Nephron-sparing surgery for bilateral Wilms tumor. Pediatr Surg Int. 2015 Mar;31(3):229-36. Abstract

193. Speafico F, Pritchard Jones K, Malogolowkin MH, et al. Treatment of relapsed Wilms tumors: lessons learned. Expert Rev Anticancer Ther. 2009 Dec;9(12):1807-15. Abstract

194. Burgers JM, Tournade MF, Bey P, et al. Abdominal recurrences in Wilms tumours: a report from the SIOP Wilms tumour trials and studies. Radiother Oncol. 1986 Mar;5(3):175-82. Abstract

195. Pein F, Michon J, Valteau-Couanet D, et al. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study. J Clin Oncol. 1998 Oct;16(10):3295-3301. Abstract

196. Presson A, Moore TB, Kempert P, et al. Efficacy of high-dose chemotherapy and autologous stem cell transplant for recurrent Wilms' tumor: a meta-analysis. J Pediatr Hematol Oncol. 2010 Aug;32(6):454-61. Abstract

197. Venkatramani R, Malogolowkin MH, Mascarenhas L. Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab. Pediatr Blood Cancer. 2014 Apr;61(4):756-9. Abstract

198. Malogolowkin M, Spreafico F, Dome JS, et al. Incidence and outcomes of patients with late recurrence of Wilms' tumor. Pediatr Blood Cancer. 2013 Oct;60(10):1612-5. Abstract

199. Spreafico F, Terenziani M, Testa S, et al. Long-term renal outcome in adolescent and young adult patients nephrectomized for unilateral Wilms tumor. Pediatr Blood Cancer. 2014 Jun;61(6):1136-7. Abstract

200. Green DM, Breslow NE, D'Angio GJ, et al. Outcome of patients with stage II/favorable histology Wilms tumor with and without local tumor spill: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer. 2014 Jan;61(1):134-9. Abstract

201. Powis M, Messahel B, Hobson R, et al. Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial. J Pediatr Surg. 2013 Nov;48(11):2181-6. Abstract

202. van den Heuvel-Eibrink MM, van Tinteren H, Bergeron C, et al. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG). Eur J Cancer. 2015;51:498-506. Abstract

203. Dome JS, Fernandez CV, Mullen EA, et al. Children's Oncology Group's 2013 blueprint for research: renal tumors. Pediatr Blood Cancer. 2013 Jun;60(6):994-1000. Abstract

204. Romão RL, Pippi Salle JL, Shuman C, et al. Nephron sparing surgery for unilateral Wilms tumor in children with predisposing syndromes: single center experience over 10 years. J Urol. 2012 Oct;188(4 suppl):1493-8. Abstract

205. Wilde JC, Aronson DC, Sznajder B, et al. Nephron sparing surgery (NSS) for unilateral Wilms tumor (UWT): the SIOP 2001 experience. Pediatr Blood Cancer. 2014 Dec;61(12):2175-9. Abstract

206. Cost NG, Sawicz-Birkowska K, Kajbafzadeh AM, et al. A comparison of renal function outcomes after nephron-sparing surgery and radical nephrectomy for nonsyndromic unilateral Wilms tumor. Urology. 2014 Jun;83(6):1388-93. Abstract

207. Termuhlen AM, Tersak JM, Liu Q, et al. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011 Dec 15;57(7):1210-6. Abstract

208. Nakadate H, Yokomori K, Watanabe N, et al. Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan. Int J Cancer. 2001 Nov 1;94(3):396-400.Full text  Abstract

209. Messahel B, Williams R, Ridolfi A, et al. Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) study. Eur J Cancer. 2009 Mar;45(5):819-26. Abstract

210. Ehrlich PF, Anderson JR, Ritchey ML, et al. Clinicopathologic findings predictive of relapse in children with stage III favorable-histology Wilms tumor. J Clin Oncol. 2013 Mar 20;31(9):1196-201. Abstract

211. Kist-van Holthe JE, Ho PL, Stablein D, et al. Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant. 2005 Jun;9(3):305-10. Abstract

212. Amirian ES. The role of Hispanic ethnicity in pediatric Wilms' tumor survival. Pediatr Hematol Oncol. 2013 May;30(4):317-27. Abstract

213. Wright KD, Green DM, Daw NC. Late effects of treatment for Wilms tumor. Pediatr Hematol Oncol. 2009 Sep;26(6):407-13. Abstract

214. Mclnerney DP, Bullimore J. Reactivation of radiation pneumonitis by adriamycin. Br J Radiol. 1977 Mar;50(591):224-7. Abstract

215. Pein F, Tournade MF, Zucker JM, et al. Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms tumor: a phase II study by the French Society of Pediatric Oncology. J Clin Oncol. 1994 May;12(5):931-6. Abstract

216. Bisogno G, de Krake J, Weirich A, et al. Veno-occlusive disease of the liver in children treated for Wilms tumor. Med Pediatr Oncol. 1997 Oct;29(4):245-51. Abstract

217. Cesaro S, Spiller M, Sartori MT, et al. Veno-occlusive disease in pediatric patients affected by Wilms tumor. Pediatr Blood Cancer. 2011 Aug;57(2):258-61. Abstract

218. Sudour H, Audry G, Schleimacher G, et al. Bilateral wilms tumors (WT) treated with the SIOP 93 protocol in France: epidemiological survey and patient outcome. Pediatr Blood Cancer. 2012 Jul 15;59(1):57-61. Abstract

219. Grigoriev Y, Lange J, Peterson SM, et al. Treatments and outcomes for end-stage renal disease following Wilms tumor. Pediatr Nephrol. 2012 Aug;27(8):1325-33. Abstract

220. Breslow NE, Lange JM, Friedman DL, et al. Secondary malignant neoplasms after Wilms tumor: an international collaborative study. Int J Cancer. 2010 Aug 1;127(3):657-66.Full text  Abstract

221. Sinisi AA, D'Apuzzo A, Pasquali D, et al. Antisperm antibodies in prepubertal boys treated with chemotherapy for malignant or non-malignant diseases and in boys with genital tract abnormalities. Int J Androl. 1997 Feb;20(1):23-8. Abstract

222. Nussbaum Blask AR, Nicholson HS, Markle BM, et al. Sonographic detection of uterine and ovarian abnormalities in female survivors of Wilms tumor treated with radiotherapy. AJR Am J Roentgenol. 1999 Mar;172(3):759-63. Abstract

223. Gow KW, Barnhart DC, Hamilton TE, et al. Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committee. J Pediatr Surg. 2013 Jan;48(1):34-8. Abstract

224. Green DM. Evaluation of renal function after successful treatment for unilateral, non-syndromic Wilms tumor. Pediatr Blood Cancer. 2013 Dec;60(12):1929-35. Abstract

225. Kern AJ, Inouye B, Ko JS, et al. Impact of nephrectomy on long-term renal function in non-syndromic children treated for unifocal Wilms tumor. J Pediatr Urol. 2014 Aug;10(4):662-6. Abstract

226. Kishore SS, Oberoi S, Bhattacharya A, et al. Function and size of the residual kidney after treatment of Wilms tumor. Pediatr Hematol Oncol. 2015 Feb;32(1):11-7. Abstract

Use of this content is subject to our disclaimer